Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ALHEMO (concizumab-mtci)
Published Date: 1/15/2025
Notice
Summary
The FDA just gave a special fast-track ticket called a Priority Review Voucher to Novo Nordisk for their new rare pediatric disease drug, ALHEMO, approved in December 2024. This voucher helps speed up the review of future medicines, benefiting patients with rare diseases and encouraging companies to develop more treatments. This move affects drug makers and could speed up new medicine approvals, saving time and possibly money.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
ALHEMO Approved for Hemophilia Prophylaxis
ALHEMO (concizumab-mtci) was approved on December 20, 2024 for routine prophylaxis to prevent or reduce bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A with FVIII inhibitors and hemophilia B with FIX inhibitors. If you or a child in your care is in those groups, ALHEMO is an FDA‑approved treatment option as of that date.
Priority Review Voucher Issued to Sponsor
The FDA issued a Priority Review Voucher under section 529 of the FD&C Act to the sponsor of the ALHEMO application (manufactured by Novo Nordisk, Inc.). The notice states ALHEMO met the criteria for a rare pediatric disease priority review voucher following its approval on December 20, 2024.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11967 — Actions Taken at the June 4, 2026 Meeting
On June 4, 2026, the Susquehanna River Basin Commission gave the green light to several water projects in Pennsylvania, including new and renewed water withdrawals. They also updated their budget and water program, extended an emergency certificate, and secured important grants. These moves affect local communities and businesses by managing water use carefully, with some projects allowing up to 5 million gallons per day, starting immediately.
2026-11929 — Fiberglass Door Panels From the People's Republic of China: Final Affirmative Countervailing Duty Determination
The U.S. Department of Commerce found that Chinese fiberglass door panel makers got unfair government help, so they’re adding extra taxes to these imports starting June 15, 2026. This affects companies importing these door panels from China, making them cost more and leveling the playing field for U.S. businesses. The decision covers the whole year of 2024 and aims to keep trade fair and square.
2026-11980 — Administrative Declaration of an Economic Injury Disaster for the State of Rhode Island
Rhode Island businesses hit by the historic snowstorm from February 22-24, 2026, can now apply for special low-interest disaster loans to help recover. This includes companies in nearby counties of Rhode Island, Connecticut, and Massachusetts. Applications are open until March 10, 2027, so don’t miss your chance to get financial help and bounce back stronger!
2026-11972 — National Vaccine Injury Compensation Program; List of Petitions Received
The National Vaccine Injury Compensation Program helps people who believe they were hurt by certain vaccines get money without a long court fight. HRSA just shared a list of new petitions filed, which means folks are asking for compensation now. If you or someone you know is affected, keep an eye on deadlines and possible payouts coming from these claims.
2026-11930 — Fiberglass Door Panels From People's Republic of China: Final Affirmative Determination of Sales at Less Than Fair Value
The U.S. Department of Commerce found that fiberglass door panels from China are being sold in the U.S. for less than their fair price. This means importers of these panels will face new duties starting June 15, 2026, to protect American businesses. If you buy or sell these door panels, get ready for some changes that could affect prices and timing.
2026-11922 — Self-Regulatory Organizations; Green Impact Exchange, LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend Rule 11.240 (Trade Reporting and Dissemination of Quotations) To Conform With Amendments to Rules 600 and 603 of Regulation NMS Approved by the Commission That Concern the Reporting and Dissemination of Odd-Lot Information, and an Additional Ministerial Change to Rule 11.220 To Correct a Typographical Error
Green Impact Exchange is updating its trade reporting rules to match new federal rules about sharing odd-lot trade info (small stock orders). They’re also fixing a tiny typo in another rule. These changes take effect right away and help keep trading info clear and accurate for everyone involved.
Previous / Next Documents
Previous: 2025-00749 — Qualification of Drivers; Exemption Applications; Implantable Cardioverter Defibrillators (ICDs)
The FMCSA got requests from two people with special heart devices called ICDs who want to drive big commercial trucks across state lines. Normally, folks with certain heart problems can’t drive these trucks, but if these exemptions are approved, these drivers could hit the road again. You’ve got until February 14, 2025, to share your thoughts—no money changes yet, just a chance to speak up!
Next: 2025-00752 — Arts Advisory Panel Meetings
The National Endowment for the Arts is holding four online meetings to review and decide on grant applications for jazz fellowships, arts education, and international arts activities. These meetings happen between February and March 2025 and are closed to the public because they involve private financial discussions. Artists, educators, and organizations applying for funding should watch these dates closely as decisions could impact their support.